Ventas Pharmaceuticals Private Limited

Ventas Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U74999DL2018PTC330780 Incorporated 13 March 2018 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2024
₹25.71 Lakh
▲ 49% YoY
Net profit · FY 2024
₹22,560
Net margin 0.9%
EBITDA · FY 2024
₹22,560
EBITDA margin 0.9%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Ventas Pharmaceuticals Private Limited

Data last updated:

Ventas Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 March 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC330780. Its GSTIN is 07AAGCV3281R1ZL (Delhi).

The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Gautam Kumar and Umesh Kumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. 523 First Floor Block – Aw Sanjay Gandhi Transport Nagar, Delhi, India – 110042.

As per the financials filed for FY 2024, the company reported a revenue of ₹25.71 Lakh, a growth of 49% compared to the previous year. For the same year it recorded a net profit of ₹22,560 (net margin 0.9%) and EBITDA of ₹22,560 (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 10% over five years.

Ventas Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0015773).

Company details

CIN U74999DL2018PTC330780
Registration Number 330780
Incorporation Date 13 March 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-06-0015773
Key People
Gautam Kumar Director Umesh Kumar Director Rajiv Kumar Director

Recognitions & Rankings of Ventas Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-DL-06-0015773

Contact details

Ventas Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    H. No. 523 First Floor Block – Aw Sanjay Gandhi Transport Nagar, Delhi, India – 110042
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Ventas Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Ventas Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ventas Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Ventas Pharmaceuticals Private Limited, buy the company report.

Financials of Ventas Pharmaceuticals Private Limited

FY 2025 filings available

Ventas Pharmaceuticals Private Limited reported revenue of ₹25.71 Lakh (up 49% YoY) for FY 2024.

Revenue · FY 2024
₹25.71 Lakh ▲ 49%
Net profit · FY 2024
₹22,560 margin 0.9%
EBITDA · FY 2024
₹22,560 margin 0.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 49%
3 years · compounded
▼ 10%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 116%
3 years · compounded
▲ 36%
5 years · compounded
▲ 6%

Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 49% growth in the latest year. EBITDA rose 116% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹22,560
Profit Before Tax
Tax Expense
Net Profit (PAT)₹22,560
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin0.9%
Net Profit Margin0.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ventas Pharmaceuticals Private Limited, buy the company report.

Board of directors of Ventas Pharmaceuticals Private Limited

Ventas Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Gautam KumarDirector13 Mar 20188 Years 7 MonthsCurrent
Umesh KumarDirector13 Mar 20188 Years 7 MonthsCurrent
Rajiv KumarDirector13 Mar 20188 Years 7 MonthsCurrent
View all directors

Peer comparison

Ventas Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Shree Govardhan Pharma Private Limited₹25.75 Lakh (FY 2025)774.0%Jaipur, Rajasthan, India
Astragenex Pharmaceuticals Private Limited₹25.74 Lakh (FY 2022)Noida, Uttar Pradesh, India
Austin Lifesciences Private Limited₹25.74 Lakh (FY 2022)-48.0%Pune, Maharashtra, India
Ventas Pharmaceuticals Private Limitedthis company₹25.71 Lakh (FY 2024)₹22,5600.9%49.0%Delhi, India
Alcuris Pharmaceuticals Private Limited₹25.67 Lakh (FY 2024)-14.0%Lucknow, Uttar Pradesh, India

To see the full peer comparison of Ventas Pharmaceuticals Private Limited, buy the company report.

Auditor

Ventas Pharmaceuticals Private Limited is audited by A M K N & CO for the financial year 2022.

Auditor firmFinancial yearFirm registration number
A M K N & COFY 2022032712C

Shareholding

The shareholding of Ventas Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Ventas Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ventas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Ventas Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAGCV3281R1ZLDelhiActive17 Apr 2018

To see the full GST registrations and return filing status of Ventas Pharmaceuticals Private Limited, buy the company report.

Recent activity

Ventas Pharmaceuticals Private Limited has 4 board changes on record since 2018: 3 appointments and 1 cessation. The latest: Kamod Kumar Gupta ceased to be Director on 25 Feb 2022.

AGM
Ventas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ventas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Kamod Kumar Gupta ceased to be Director.
Appointed
Gautam Kumar was appointed as Director.
Appointed
Rajiv Kumar was appointed as Director.
Appointed
Umesh Kumar was appointed as Director.
Incorporation
13 Mar 2018
Ventas Pharmaceuticals Private Limited was registered on 13 Mar 2018 with Roc Delhi Ii & aged 8 years 7 months as per MCA records.

Frequently asked questions

Ventas Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 March 2018 (8+ years old) and is registered under CIN U74999DL2018PTC330780.

Ventas Pharmaceuticals has 3 current directors:

The latest financial statements of Ventas Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Ventas Pharmaceuticals is 07AAGCV3281R1ZL, registered in Delhi.

The CIN (Corporate Identification Number) of Ventas Pharmaceuticals is U74999DL2018PTC330780. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ventas Pharmaceuticals was incorporated on 13 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Ventas Pharmaceuticals by revenue are Shree Govardhan Pharma Private Limited, Astragenex Pharmaceuticals Private Limited, Austin Lifesciences Private Limited, Alcuris Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Kamod Kumar Gupta ceased to be Director on 25 Feb 2022. Gautam Kumar was appointed as Director on 13 Mar 2018. Rajiv Kumar was appointed as Director on 13 Mar 2018. Ventas Pharmaceuticals has 4 board changes on record in total.

Yes, Ventas Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0015773).

The registered office of Ventas Pharmaceuticals is at H. No. 523 First Floor Block – Aw Sanjay Gandhi Transport Nagar, Delhi, India – 110042.

Ventas Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.